References
- Cupertino MC, Garcia R, Gomes AP, et al. Epidemiological, prevention and control updates of yellow fever outbreak in Brazil. Asian Pac J Trop Med. 2019;12(2):49.
- Freitas CS, Higa LM, Sacramento CQ, et al. Yellow fever virus is susceptible to sofosbuvir both in vitro and in vivo. PLoS Negl Trop Dis. 2019;13(1):e0007072.
- Sovaldi: sofosbuvir. Irlanda: gilead Sciences Ireland UC, 2014. Medicine bottle. [cited 2019 May 20]. Available from: https://www.ema.europa.eu/en/documents/product-information/sovaldi-epar-product-information_pt.pdf
- Ferreira AC, Reis PA, Freitas CS, et al. Beyond members of the Flaviviridae family, sofosbuvir also inhibits chikungunya virus replication. Antimicrob Agents Chemother. 2019;63(2):e01389–18.
- Gan CS, Lim SK, Chee CF, et al. Sofosbuvir as treatment against dengue? Chem Biol Drug Des. 2018;91(2):448–455.